Michelson Diagnostics (Kent, UK) plans to release soon a new optical coherence tomography (OCT) probe. OCT is a fairly new player in the world of medical imaging, relying on interferometric analysis of scattered light beams to penetrate biological tissue and see what’s below the surface. Michelson believes that its proprietary multi-beam technology will result in higher quality clinical OCT imaging.
From the press release and preliminary specs:
Two variants of the new Vivosight probe are specified, one is a version with X-Y scanning, to enable 3D mapping of flat tissue such as skin, and the other is a version equipped with a rigid endoscope, suitable for internal applications. The unique multi-beam design provides double the image resolution (i.e. better than 10 μm) available from conventional single-beam designs, resulting in crisper, clearer OCT images, showing more clinical detail.
The Vivosight scanner with hand-held Multi-Beam OCT probe has been designed by Michelson Diagnostics engineers specifically for clinical applications. The patented Multi-Beam optics provide double the image resolution available to single-beam OCT systems – better than 10 μm axial and lateral, simultaneously. The hand-held probe will be available with either stub lens for topical uses, or with a replaceable autoclavable rigid endoscope.
Press release: Michelson Diagnostics releases preliminary specification for clinical hand-held OCT probe
Vivosight OCT preliminary datasheet (PDF)…
Product page: Vivosight
Flashbacks: OFDI Scanner Takes a Good Intra Arterial Look; Tomophase OCT System and the Future of Pulmonary Diagnostics; Optical Coherence Tomography for Multiple Sclerosis; FDA Approves Optical Coherence Tomography (OCT); Optical Coherence Tomography System by Imalux